0001743192-21-000004.txt : 20211122
0001743192-21-000004.hdr.sgml : 20211122
20211119201226
ACCESSION NUMBER: 0001743192-21-000004
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20211122
DATE AS OF CHANGE: 20211119
EFFECTIVENESS DATE: 20211122
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Starton Therapeutics Inc.
CENTRAL INDEX KEY: 0001743192
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-421938
FILM NUMBER: 211429933
BUSINESS ADDRESS:
STREET 1: 215 COLLEGE ROAD, SUITE #300
CITY: PARAMUS
STATE: NJ
ZIP: 07652
BUSINESS PHONE: 800-449-5405
MAIL ADDRESS:
STREET 1: 215 COLLEGE ROAD, SUITE #300
CITY: PARAMUS
STATE: NJ
ZIP: 07652
FORMER COMPANY:
FORMER CONFORMED NAME: ChemioCare Inc.
DATE OF NAME CHANGE: 20180608
D
1
primary_doc.xml
X0708
D
LIVE
0001743192
Starton Therapeutics Inc.
215 COLLEGE ROAD, SUITE #300
PARAMUS
NJ
NEW JERSEY
07652
800-449-5405
BRITISH COLUMBIA, CANADA
ChemioCare Inc.
Corporation
true
2017
Pedro
Waisman
215 College Road, Suite 300
Paramus
NJ
NEW JERSEY
07652
Executive Officer
Director
Cidnee
Vaykovich
215 College Road, Suite 300
Paramus
NJ
NEW JERSEY
07652
Executive Officer
Director
Fotios
Plakogiannis
215 College Road, Suite 300
Paramus
NJ
NEW JERSEY
07652
Director
Nitin
Kaushal
215 College Road, Suite 300
Paramus
NJ
NEW JERSEY
07652
Director
Eric
Baum
215 College Road, Suite 300
Paramus
NJ
NEW JERSEY
07652
Director
Roy
Waldron
215 College Road, Suite 300
Paramus
NJ
NEW JERSEY
07652
Director
Mohamad
Hussein
215 College Road, Suite 300
Paramus
NJ
NEW JERSEY
07652
Director
Kenneth
Anderson
215 College Road, Suite 300
Paramus
NJ
NEW JERSEY
07652
Director
Asher
Chanan-Khan
215 College Road, Suite 300
Paramus
NJ
NEW JERSEY
07652
Director
Keith
Darragh
215 College Road, Suite 300
Paramus
NJ
NEW JERSEY
07652
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06b
false
2021-10-19
false
true
false
0
1145375
1145375
0
false
39
0
0
0
false
Starton Therapeutics Inc.
/s/Keith Darragh
Keith Darragh
Chief Financial Officer
2021-11-19